Development of a size-restricted pIX-deleted helper virus for amplification of helper-dependent adenovirus vectors
- 1 March 2004
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 11 (6) , 504-511
- https://doi.org/10.1038/sj.gt.3302107
Abstract
Helper-dependent adenovirus vectors (hdAd), which are deleted of all viral protein-coding sequences, can mediate long-term expression of a therapeutic transgene and lead to life-long, phenotypic correction in animal models of genetic disease. Here, we describe a new system for the generation of hdAd, which utilizes the DNA size restrictions imposed on an Ad virion deleted of protein IX (pIX): such virions are reported to package up to only 35 kb of viral DNA. A pIX- helper virus (37.3 kb) was easily grown on complementing 293pIX cells. Upon infection of noncomplementing cells, this virus was not capable of forming infectious virions, but provided replicative and packaging functions for propagation of a 30-kb hdAd. The pIX- helper virus was effective in amplifying an hdAd and, in combination with Cre-mediated excision in the viral-packaging signal, resulted in a 1000-fold reduction in helper virus contamination in hdAd stocks compared to Cre/lox alone, as determined by plaque assay. However, through slot blot analysis of DNA isolated from virions, we determined that the ratio of hdAd to helper DNA was 500:1, similar to the ratio observed when using Cre/lox alone. Surprisingly, a large amount of the 37.3-kb helper DNA was being packaged into the pIX-deleted virions, but these virions were incapable of establishing productive infections in plaque assays, for reasons which are still unclear. Nevertheless, the pIX- hdAd generated in this system infected cells and expressed a transgene at levels similar to those obtained with a pIX+ hdAd. These data suggest that, although further studies are necessary to characterize the nature of the defective helper virions formed in this system, deletion of pIX from the helper virus genome does provide an effective method to prevent recovery of functional helper virus during hdAd amplification.Keywords
This publication has 44 references indexed in Scilit:
- Gutted adenoviral vector growth using E1/E2b/E3‐deleted helper virusesThe Journal of Gene Medicine, 2002
- Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vectorProceedings of the National Academy of Sciences, 2001
- Efficient FLPe recombinase enables scalable production of helper-dependent adenoviral vectors with negligible helper-virus contaminationNature Biotechnology, 2001
- Development of a FLP/frt System for Generating Helper-Dependent Adenoviral VectorsMolecular Therapy, 2001
- A Cre-Expressing Cell Line and an E1/E2a Double-Deleted Virus for Preparation of Helper-Dependent Adenovirus VectorMolecular Therapy, 2001
- High Doses of a Helper-Dependent Adenoviral Vector Yield Supraphysiological Levels ofα1-Antitrypsin with Negligible ToxicityHuman Gene Therapy, 1998
- Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicityNature Genetics, 1998
- Immune Responses to Reporter Proteins and High Viral Dose Limit Duration of Expression with Adenoviral Vectors: Comparison of E2a Wild Type and E2a Deleted VectorsHuman Gene Therapy, 1997
- A helper-dependent adenovirus vector system: Removal of helper virus by Cre-mediated excision of the viral packaging signalProceedings of the National Academy of Sciences, 1996
- Pulmonary Inflammation Induced by Incomplete or Inactivated Adenoviral ParticlesHuman Gene Therapy, 1995